Combivir News
CROI: HAART use in mothers substantially reduces HIV infections in ... - Aidsmap
From July 2003 to January 2005, the HAART regimens consisted of Combivir (300 mg zidovudine / 150 mg lamivudine) twice daily, plus nevirapine. ...
Maraviroc-Based Antiretroviral Treatment Appears Neutral in ... - DG News
... (Combivir) than for those receiving maraviroc plus Combivir," said Edwin DeJesus, MD, Medical Director, Orlando Immunology Center, Orlando, Florida. ...
Switching From Zidovudine- to Tenofovir-Based Therapy Preserves ... - DG News
By Maria Bishop BOSTON, MA -- February 6, 2008 -- Patients with HIV who switch from a combination of zidovudine and lamivudine (Combivir) to tenofovir plus ...
Kaletra monotherapy studies yield conflicting results - Aidsmap
In this prospective clinical trial, 136 treatment-naive patients were randomised to either Kaletra alone or with 3TC/AZT (Combivir) as an initial regimen. ...
Kaletra monotherapy studies yield conflicting results - Aidsmap
In this prospective clinical trial, 136 treatment-naive patients were randomised to either Kaletra alone or with 3TC/AZT (Combivir) as an initial regimen. ...
HIV-positive patients have high prevalence of asymptomatic heart ... - Aidsmap
... or more was associated with asymptomatic narrowing of the coronary artery (p = 0.02) as was six months or more of treatment with Combivir (p = 0.043). ...
Pharma set for small buys in ’08 - Hindustan Times
Many life saving drugs are combinations like Cipla’s Combivir, a medicine for the treatment of AIDS. Mergers and acquisitions too have turned mostly ...
Pharma set for small buys in ’08 - Hindustan Times
Many life saving drugs are combinations like Cipla’s Combivir, a medicine for the treatment of AIDS. Mergers and acquisitions too have turned mostly ...
Pfizer India Surges on Winning Patent for AIDS Drug (Update2) - Bloomberg
GlaxoSmithKline Plc, the world's second-biggest drugmaker, withdrew patent application for its AIDS drug Combivir in August last year after opposition from ...
WHO demands more tailor-made treatments for children - Pharma Times (subscription)
... approval from the European Commission for a new indication for use in infants of its HIV combination medicine Combivir (zidovudine and lamivudine). ...
Combivir RSS Feed